Xenetic Biosciences
XBIO

Xenetic Biosciences (XBIO) earnings history

Most recent quarter

Period end
Mar 31, 2025
EPS actual
−$0.59
EPS estimate
−$0.72
Revenue
$590,000.00
Revenue estimate
$670,000.00
Reported
May 13, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q1 2025May 13, 2025−$0.72−$0.59+18.06%$590,000.00SEC
Q4 2024Mar 18, 2025−$0.68−$0.68+0.00%$650,000.00SEC
Q3 2024Nov 12, 2024−$0.14−$0.28−100.00%$614,243.00SEC
Q2 2024Aug 13, 2024−$0.83−$0.83+0.00%$726,404.00SEC
Q1 2024May 9, 2024−$0.78−$0.78+0.00%$510,817.00SEC
Q4 2023Mar 21, 2024−$0.76−$0.76+0.00%$670,000.00SEC
Q1 2022May 12, 2022−$1.20−$1.20+0.00%$390,000.00
Q3 2021Nov 12, 2021−$1.20−$1.30−8.33%$349,269.00
Q2 2021Aug 12, 2021−$1.30−$1.30+0.00%$287,603.00
Q1 2020May 14, 2020−$3.70−$1.90+48.65%$58,500.00

Quarterly revenue

Q1 2020
$58,500.00
Q2 2021
$287,603.00
Q3 2021
$349,269.00
Q1 2022
$390,000.00
Q4 2023
$670,000.00
Q1 2024
$510,817.00
Q2 2024
$726,404.00
Q3 2024
$614,243.00
Q4 2024
$650,000.00
Q1 2025
$590,000.00

Frequently asked questions

  • When did Xenetic Biosciences (XBIO) last report earnings?

    Xenetic Biosciences last reported on May 13, 2025, covering fiscal Q1 2025.

  • Did XBIO beat earnings estimates?

    Yes. Xenetic Biosciences reported EPS of −$0.59 for Q1 2025 against a −$0.72 estimate — a 18.06% beat.

  • How much revenue did XBIO report last quarter?

    Xenetic Biosciences reported $590,000.00 in revenue for Q1 2025, against a consensus estimate of $670,000.00.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.